1007 related articles for article (PubMed ID: 19286037)
1. Detection of anabolic androgenic steroid abuse in doping control using mammalian reporter gene bioassays.
Houtman CJ; Sterk SS; van de Heijning MP; Brouwer A; Stephany RW; van der Burg B; Sonneveld E
Anal Chim Acta; 2009 Apr; 637(1-2):247-58. PubMed ID: 19286037
[TBL] [Abstract][Full Text] [Related]
2. Detection of anabolic steroid abuse using a yeast transactivation system.
Zierau O; Lehmann S; Vollmer G; Schänzer W; Diel P
Steroids; 2008 Oct; 73(11):1143-7. PubMed ID: 18550137
[TBL] [Abstract][Full Text] [Related]
3. Urine testing for designer steroids by liquid chromatography with androgen bioassay detection and electrospray quadrupole time-of-flight mass spectrometry identification.
Nielen MW; Bovee TF; van Engelen MC; Rutgers P; Hamers AR; van Rhijn JH; Hoogenboom LR
Anal Chem; 2006 Jan; 78(2):424-31. PubMed ID: 16408923
[TBL] [Abstract][Full Text] [Related]
4. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays.
Sonneveld E; Jansen HJ; Riteco JA; Brouwer A; van der Burg B
Toxicol Sci; 2005 Jan; 83(1):136-48. PubMed ID: 15483189
[TBL] [Abstract][Full Text] [Related]
5. Efficient approach for the comprehensive detection of unknown anabolic steroids and metabolites in human urine by liquid chromatography-electrospray-tandem mass spectrometry.
Pozo OJ; Deventer K; Eenoo PV; Delbeke FT
Anal Chem; 2008 Mar; 80(5):1709-20. PubMed ID: 18220370
[TBL] [Abstract][Full Text] [Related]
6. Advantages and Limitations of Androgen Receptor-Based Methods for Detecting Anabolic Androgenic Steroid Abuse as Performance Enhancing Drugs.
Bailey K; Yazdi T; Masharani U; Tyrrell B; Butch A; Schaufele F
PLoS One; 2016; 11(3):e0151860. PubMed ID: 26998755
[TBL] [Abstract][Full Text] [Related]
7. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
Gosetti F; Mazzucco E; Gennaro MC; Marengo E
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
[TBL] [Abstract][Full Text] [Related]
8. Liquid chromatographic-mass spectrometric analysis of glucuronide-conjugated anabolic steroid metabolites: method validation and interlaboratory comparison.
Hintikka L; Kuuranne T; Leinonen A; Thevis M; Schänzer W; Halket J; Cowan D; Grosse J; Hemmersbach P; Nielen MW; Kostiainen R
J Mass Spectrom; 2008 Jul; 43(7):965-73. PubMed ID: 18563858
[TBL] [Abstract][Full Text] [Related]
9. Mass spectrometry in sports drug testing: Structure characterization and analytical assays.
Thevis M; Schänzer W
Mass Spectrom Rev; 2007; 26(1):79-107. PubMed ID: 16888758
[TBL] [Abstract][Full Text] [Related]
10. 17beta-hydroxy-5alpha-androst-1-en-3-one (1-testosterone) is a potent androgen with anabolic properties.
Friedel A; Geyer H; Kamber M; Laudenbach-Leschowsky U; Schänzer W; Thevis M; Vollmer G; Zierau O; Diel P
Toxicol Lett; 2006 Aug; 165(2):149-55. PubMed ID: 16621347
[TBL] [Abstract][Full Text] [Related]
11. Hair analysis of anabolic steroids in connection with doping control-results from horse samples.
Anielski P
J Mass Spectrom; 2008 Jul; 43(7):1001-8. PubMed ID: 18563854
[TBL] [Abstract][Full Text] [Related]
12. Androgenic-anabolic steroids and the Olympic Games.
Fitch KD
Asian J Androl; 2008 May; 10(3):384-90. PubMed ID: 18385900
[TBL] [Abstract][Full Text] [Related]
13. Characterization of identity, metabolism and androgenic activity of 17-hydroxyandrosta-3,5-diene by GC-MS and a yeast transactivation system.
Bauer A; Rataj F; Zierau O; Anielski P; Große J; Parr MK; Vollmer G; Thieme D
Arch Toxicol; 2012 Dec; 86(12):1873-84. PubMed ID: 22811023
[TBL] [Abstract][Full Text] [Related]
14. Validation and application of a yeast bioassay for screening androgenic activity in calf urine and feed.
Bovee TF; Bor G; Heskamp HH; Lasaroms JJ; Sanders MB; Nielen MW
Anal Chim Acta; 2009 Apr; 637(1-2):225-34. PubMed ID: 19286034
[TBL] [Abstract][Full Text] [Related]
15. Comparison of in vitro and in vivo screening models for androgenic and estrogenic activities.
Sonneveld E; Riteco JA; Jansen HJ; Pieterse B; Brouwer A; Schoonen WG; van der Burg B
Toxicol Sci; 2006 Jan; 89(1):173-87. PubMed ID: 16221957
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of androgenic activity of nutraceutical-derived steroids using mammalian and yeast in vitro androgen bioassays.
Akram ON; Bursill C; Desai R; Heather AK; Kazlauskas R; Handelsman DJ; Lambert G
Anal Chem; 2011 Mar; 83(6):2065-74. PubMed ID: 21329390
[TBL] [Abstract][Full Text] [Related]
17. Emerging drugs: mechanism of action, mass spectrometry and doping control analysis.
Thevis M; Thomas A; Kohler M; Beuck S; Schänzer W
J Mass Spectrom; 2009 Apr; 44(4):442-60. PubMed ID: 19373874
[TBL] [Abstract][Full Text] [Related]
18. Searching for new markers of endogenous steroid administration in athletes: "looking outside the metabolic box".
Cawley AT; Hine ER; Trout GJ; George AV; Kazlauskas R
Forensic Sci Int; 2004 Jul; 143(2-3):103-14. PubMed ID: 15240029
[TBL] [Abstract][Full Text] [Related]
19. Detection of glucocorticoid bioactivity in bovine urine samples using a reporter gene assay.
Connolly L; Cai K; Van der Heiden E; Scippo ML; Muller M; Tarbin J; Elliott C
Anal Chim Acta; 2009 Apr; 637(1-2):321-7. PubMed ID: 19286046
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometry of selective androgen receptor modulators.
Thevis M; Schänzer W
J Mass Spectrom; 2008 Jul; 43(7):865-76. PubMed ID: 18521833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
